NMN and Resveratrol: Should You Take Them Together?
NMN and resveratrol are a popular longevity stack, but human synergy is unproven. We examine the mouse combination study, tissue NAD+ results, timing, TMG and what personal routines...
Evidence library 30 analyses
A research hub for NMN and NAD+ biology, covering human trials, dosing, safety, bioavailability and longevity claims.
Complete library
Browse every published guide, review and evidence update in this topic.
NMN and resveratrol are a popular longevity stack, but human synergy is unproven. We examine the mouse combination study, tissue NAD+ results, timing, TMG and what personal routines...
Independent studies have found major label failures and isomer inconsistencies in commercial NMN. This guide shows how to read a COA, verify batch potency and distinguish meaningful testing...
This living evidence map separates independent NMN trials from post-hoc and secondary publications, covering safety, NAD+, insulin sensitivity, exercise, sleep, blood pressure, diabetes and disease-specific studies through September...
Human trials do not support one mandatory NMN timing ritual. This guide explains morning vs afternoon, food, fasting, split dosing, sublingual use, cycling, storage and common stacking questions.
Liposomal NMN is marketed as more bioavailable, but direct human superiority data are missing. We compare standard oral, sublingual, powder, microcrystalline and liposomal forms using current pharmacokinetic evidence.
NMN's U.S. regulatory position changed in 2025. This guide explains FDA drug-preclusion status, NDI 1444, EU novel-food authorization, EFSA's 2026 opinion and the current UK application.
The 2026 head-to-head trial found similar whole-blood NAD+ increases from 1,000 mg/day NMN and NR. We compare pathways, pharmacology, evidence, safety and the claims that no longer hold...
NMN is a precursor; NAD+ is the cellular coenzyme. This guide explains why pathway position does not automatically make one supplement superior and compares the actual human evidence.
Short-term NMN trials are broadly reassuring, but long-term safety, cancer treatment, pregnancy and product-quality risks need nuance. This review separates observed adverse events from unknowns.